Researchers have developed a breath sensor that can detect diabetes and prediabetes by measuring acetone levels in exhaled breath delivering results in minutes and offering a non-invasive alternative to traditional blood tests.
Glimpse:
A newly developed sensor based on graphene and zinc oxide can identify elevated acetone levels in breath samples, which correlate to diabetes and prediabetes. In early trials, the device distinguished between people with type 2 diabetes and healthy individuals, using just a breath sample into a bag. The team tested with over 50 diabetic and 20 non-diabetic volunteers, and the sensor showed strong sensitivity and specificity. Unlike blood tests, this breath-based method is faster, cheaper, and doesn’t require needles making it a promising tool for early screening, especially in resource-limited or community settings.
Imagine diagnosing diabetes without a finger prick. That’s the future scientists are building right now. A breath sensor being developed by researchers using laser-induced graphene combined with zinc oxide can pick up acetone levels in exhaled breath a biomarker tied to fat metabolism that spikes when the body lacks insulin.
What they’ve done: Participants exhale into a bag; the sensor, dipped into the sample, quickly measures acetone. Elevated acetone (above about 1.8 parts per million) suggests risk of diabetes or prediabetes. In a study involving roughly 50 people with type 2 diabetes and another twenty healthy volunteers, the device was able to distinguish between the two groups reliably. It also showed that its readings correlate to blood sugar levels meaning it doesn’t just flag risk, it potentially tracks the severity.
Why it matters Blood glucose tests, whether via finger-stick or lab, are accurate but invasive, costly, and often hard to scale. This breath-sensor opens up opportunities mobile health camps, point-of-care settings, or even home monitoring. Because it’s fast, cheap, and painless, many more people may be screened early, long before symptoms become serious.
Challenges remain: things like differentiating acetone from other gases (breath is humid and full of volatile compounds), ensuring consistent readings across different environments, usability in real-world settings (not just clinical trials), and regulatory approvals. Plus, the accuracy needs to be validated in larger, more diverse populations.
Still, the promise is huge. Early detection of diabetes could reduce complications, improve outcomes, and reduce healthcare costs. If this tech can be scaled well, it might help millions who don’t even realize they have prediabetes until it’s too late.
“Detecting diabetes might soon be as simple as breathing into a bag and waiting just a few minutes a step that could change lives by catching the disease early, before irreversible damage sets in.”
By
HB Team
